Form 4: ELUTIA CSO Michelle Williams' Routine Stock Activity
Insider Transaction Report
ELUTIA's Chief Scientific Officer, Michelle LeRoux Williams, reported the vesting of restricted stock units and subsequent tax-related share disposition.
Summary
- Michelle LeRoux Williams, Chief Scientific Officer of ELUTIA INC., reported transactions on March 10, 2026.
- 12,500 shares of Class A Common Stock were acquired through the vesting of restricted stock units (RSUs).
- 4,613 shares of Class A Common Stock were disposed of to satisfy tax withholding requirements at a price of $1.09 per share.
- Following these transactions, Michelle LeRoux Williams beneficially owns 109,821 shares of Class A Common Stock directly.
- 12,500 derivative securities (Restricted Stock Units) were exercised/vested, leaving 37,500 RSUs beneficially owned.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine compensation event for a key executive, reflecting standard equity incentive plan mechanics rather than a significant positive or negative operational development for the company.
Positives
- The vesting of 12,500 restricted stock units indicates a scheduled compensation event for a key executive, aligning executive incentives with shareholder value.
Negatives
- A disposition of 4,613 shares occurred to cover tax withholding obligations, which is a standard practice but results in a reduction of direct share ownership.
Future Outlook
The filing indicates a pre-defined vesting schedule for the remaining 37,500 restricted stock units, with quarterly vesting continuing until December 10, 2026.
Industry Context
StockSavvy.ai notes that this Form 4 filing details a routine insider transaction related to executive compensation. Such filings are common across all industries for publicly traded companies and reflect the standard operation of equity incentive plans, rather than specific industry trends or competitive dynamics.
Stakeholder Impact
- Shareholders: The transaction is a routine compensation event and does not indicate a significant change in company strategy or financial health. It represents a minor dilution from RSU vesting, offset by executive retention and alignment.
Next Steps
- Continued quarterly vesting of the remaining 37,500 restricted stock units on scheduled dates until December 10, 2026.
Key Dates
| Date | Description |
|---|---|
| 01/31/2024 | Grant date of 150,000 restricted stock units to the Reporting Person. |
| 06/10/2024 | First vesting date for 1/6 of the granted restricted stock units. |
| 09/10/2024 | Quarterly vesting date for 1/12 of the granted restricted stock units. |
| 12/10/2024 | Quarterly vesting date for 1/12 of the granted restricted stock units. |
| 03/10/2025 | Quarterly vesting date for 1/12 of the granted restricted stock units. |
| 06/10/2025 | Quarterly vesting date for 1/12 of the granted restricted stock units. |
| 09/10/2025 | Quarterly vesting date for 1/12 of the granted restricted stock units. |
| 12/10/2025 | Quarterly vesting date for 1/12 of the granted restricted stock units. |
| 03/10/2026 | Transaction date for RSU vesting and tax withholding. |
| 03/12/2026 | Signature date of the filing. |
| 06/10/2026 | Quarterly vesting date for 1/12 of the granted restricted stock units. |
| 09/10/2026 | Quarterly vesting date for 1/12 of the granted restricted stock units. |
| 12/10/2026 | Final quarterly vesting date for 1/12 of the granted restricted stock units. |
Recommendation
holdThis Form 4 details a routine, pre-scheduled vesting of restricted stock units and subsequent tax-related share disposition by a key executive. It does not provide new material information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing confirms standard compensation practices without altering the fundamental investment thesis.
Keywords
ELUTIA INC., ELUT, Michelle LeRoux Williams, Chief Scientific Officer, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Equity Compensation, Stock Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.